The National Institute on Aging (NIA) awarded a $490,262 Project Grant (CFDA 93.866 - Aging Research) to Plans4Care Inc. on June 15, 2025 to develop and test a digital platform called "Activities4Care". The platform aims to provide customized, evidence-based activity plans for caregivers of people living with Alzheimer's disease and related dementias. The key products to be delivered under this Fast-Track SBIR award include: A clickable prototype of the Activities4Care platform that...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $811,228 to B.A. Maze, Inc. to develop the At-Home Health Station (AHS), a plug-and-play modular system designed to simplify digital health experiences for individuals with cognitive impairment or Alzheimer's disease and related dementias (CI/ADRD). The AHS system aims to promote health function and independence through remote patient monitoring, while also providing caregivers a platform for...
The National Institute on Aging (NIA) awarded a $1,010,368 Project Grant under the Aging Research federal grant program (CFDA 93.866) to Koronis Biomedical Technologies Corp. (KBT) to develop and validate an interactive gaming platform to facilitate cognitive interventions for individuals living with mild cognitive impairment (MCI) or Alzheimer's disease and related dementias (AD/ADRD). The goal is to create an in-home cognition training system that provides evidence-based cognitive activities...
The National Institute on Aging (NIA), under the Federal Aging Research program (CFDA 93.866), awarded a $245,148 project grant to Eyenexo LLC to develop an automated rodent behavior testing system for non-invasively assessing early-stage Alzheimer's disease (AD). The project aims to develop a behavior biomarker that can differentiate AD from normal aging by studying defensive behaviors triggered by looming stimuli, which are linked to early AD pathology in the midbrain region. The 2-year...
The National Institute on Aging (NIA) awarded a $864,674 Project Grant under the Aging Research program (CFDA 93.866) to Lifebio Inc., a small disadvantaged business, to develop a tablet-based platform called LifeBioTalk. This Phase I SBIR project aims to build a prototype of LifeBioTalk, which will provide stimulating audiovisual content narrated by a human-like avatar to engage people with Alzheimer's disease and related dementias (AD/ADRD). The prototype will have the ability to record...
The Department of Health and Human Services' National Institutes of Health's National Institute on Aging awarded $865,905 under the Aging Research program (CFDA 93.866) to Careband, Inc. to develop the Appraise to Assist system. This project grant will support Careband and its partner Eperture LLC to engineer a system integrating Careband's wearable device and Eperture's tablet platform. The system aims to passively and unobtrusively monitor, empirically measure, and facilitate engagement...
This Project Grant award of $835,056, provided by the National Institute on Aging (CFDA 93.866 Aging Research), supports the development of a multi-modal system of wearable biosensors and predictive analytics to enable continuous monitoring of mobility and cognitive function in older adults. The primary goals are to: Develop a system of flexible, breathable, and inconspicuous eutectogel sensor patches that can provide real-time monitoring of biophysical domains like gait, posture, heart rate,...
The National Institute on Aging (NIA) awarded Rush River Research Corp a $375,704 Project Grant under the Aging Research federal grant program (CFDA 93.866) to develop and evaluate an innovative, low-cost chair designed to reduce the prevalence of pressure injuries among individuals living with Alzheimer's disease and related dementias (ADRD). The proposed chair aims to provide the functionality of an alternating pressure air surface mattress without the need for electricity or compressed air,...
The National Institute on Aging (NIA) awarded a $499,996 Project Grant under the Aging Research federal grant program (CFDA 93.866) to Beaver Health, Inc., a minority-owned, woman-owned small business, to develop a prototype of the COMPASS conversational AI assistant. COMPASS is designed to provide personalized, culturally responsive support and coordination for Alzheimer's disease and related dementia (ADRD) caregivers in real-time. The 12-month project aims to develop and test the initial...
The National Institute on Aging (NIA) awarded a $713,096 Project Grant (CFDA 93.866 - Aging Research) to Minnesota Healthsolutions Corporation on September 25, 2024. The goal of this project is to develop an innovative, calibrated pressure-shifting programmable chair to prevent and treat pressure injuries in persons living with Alzheimer's disease or related dementias (ADRD). The chair is designed to overcome limitations of existing pressure-relieving devices and enable widespread use in...
The National Institute on Aging (NIA) awarded a $1,249,235 Project Grant under the Aging Research federal grant program (CFDA 93.866) to Nasoni, LLC, a self-certified small disadvantaged business and manufacturer, to develop the ACTIVE-H2O smart faucet system. The smart faucet is designed to enhance independent living for individuals with Alzheimer's disease and dementia by integrating intelligent sensors, automated flow/pressure/temperature control, task reminders, and computer vision algorithms. The project aims to create a versatile faucet solution that can assist with critical activities of daily living such as drinking, grooming, medication management, and personal hygiene. Building on the company's existing faucet technology, this Phase II effort will further refine the system to better support the unique needs of people living with cognitive impairments. The grant will fund the modification, validation, and manufacturing scale-up of the ACTIVE-H2O smart faucet prototype, with the goal of deploying the technology in a field efficacy study by August 2026.